Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Common Stock par value $0.001 per share · CUSIP: 690469101
Event date: 2025-12-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 13,259,735.00 · Class: 9.9%
- Peter Kolchinsky
Shares: 13,259,735.00 · Class: 9.9%
- Rajeev Shah
Shares: 13,259,735.00 · Class: 9.9%
- RA Capital Healthcare Fund, L.P.
Shares: 13,259,735.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000079
- Form type
- SCHEDULE 13G
- Filer
- Ovid Therapeutics Inc.
- CIK
- CIK 1636651
- Filed
- Dec 18, 2025
- Reporting period
- Dec 11, 2025
- Description
- Schedule 13G beneficial ownership